Medtronic snoring treatment gets OK
- Article by: STEVE ALEXANDER
- Star Tribune
- July 11, 2012 - 11:20 PM
Medtronic said Wednesday that the Food and Drug Administration (FDA) has authorized one of its existing products to be more extensively used to treat snoring disorders.
About 90 million U.S. adults are affected by snoring problems, said Fridley-based Medtronic. The FDA action means that a patient with a snoring disorder can receive up to five of Medtronic's Pillar Palatal Implant devices, which were previously approved for treatment of airway constriction ailments such as snoring and sleep apnea.
The Medtronic device is used to stiffen the patient's soft palate tissue against a tendency to vibrate and collapse, which can block the upper respiratory airway and contribute to snoring, Medtronic said.
The latest FDA approval does not extend to sleep apnea treatment, which remains limited to three devices per patient, Medtronic said.
Steve Alexander 612-673-4553
© 2017 Star Tribune